Medical specialists from France tagged as investigators in clinical trials studying Glycogen Storage Disease Type 2
Total 20 results
-
Abdellatif TaziSeen in:
- Paris, Hopital Saint Louis
Trials:- NCT02746718 (Principal Investigator)
Conditions: -
Antoine CuvelierSeen in:
- Rouen, CHU de Rouen
Trials:- NCT02746718 (Principal Investigator)
Conditions: -
Capucine Morélot-PanziniSeen in:
- Paris, GH Pitié Salpêtrière
Trials:- NCT02746718 (Principal Investigator)
Conditions: -
Christophe PERRINSeen in:
- Cannes, CH de Cannes
Trials:- NCT02746718 (Principal Investigator)
Conditions: -
Claudio RabecSeen in:
- Dijon, CHU Le Bocage
Trials:- NCT02746718 (Principal Investigator)
Conditions: -
Florent FavardSeen in:
- Limoges, CHU de Limoges
Trials:- NCT02746718 (Principal Investigator)
Conditions: -
Gilles MangiapanSeen in:
- Créteil, CHI de Créteil
Trials:- NCT02746718 (Principal Investigator)
Conditions: -
GirardSeen in:
- Briancon, CH d'Escartons
Trials:- NCT02746718 (Principal Investigator)
Conditions: -
Hélène PRIGENTSeen in:
- Paris, Hôpital Raymond Poincaré
Trials:- NCT02746718 (Principal Investigator)
Conditions: -
Isabelle Court-FortuneSeen in:
- Saint-Étienne, CHU de St Etienne
Trials:- NCT02746718 (Principal Investigator)
Conditions: -
Julie NardiSeen in:
- Reims, Polyclinique Les Bleuets
Trials:- NCT02746718 (Principal Investigator)
Conditions: -
Julien PralineSeen in:
- Tours, CHRU de Tours
Trials:- NCT02746718 (Sub-Investigator)
Conditions: -
Laure BelmontSeen in:
- Argenteuil, Centre Hospitalier d'Argenteuil
Trials:- NCT02746718 (Principal Investigator)
Conditions: -
Laurent PLANTIERSeen in:
- Tours, CHRU de Tours
- Tours, CHRU, Tours - Hôpital Bretonneau
Trials:- NCT03939520 (Principal Investigator)
- NCT02746718 (Principal Investigator)
Conditions: -
Pereira-CorteseSeen in:
- Nice, Cabinet Dr Pereira-Cortese
Trials:- NCT02746718 (Principal Investigator)
Conditions: -
SedkaouiSeen in:
- Toulouse, CHU de Toulouse
Trials:- NCT02746718 (Principal Investigator)
Conditions: -
Thierry PEREZSeen in:
- Lille, CHRU de Lille
Trials:- NCT02746718 (Principal Investigator)
Conditions: -
TrzepizurSeen in:
- Angers, CHU d'Angers
Trials:- NCT02746718 (Principal Investigator)
Conditions: -
Ulrike LerolleSeen in:
- Trélazé, Clinique Saint Joseph
Trials:- NCT02746718 (Principal Investigator)
Conditions: -
Zakaria SaakashviliSeen in:
- Créteil, CHI de Créteil
Trials:- NCT02746718 (Sub-Investigator)
Conditions:
Clinical Trials on Glycogen Storage Disease Type 2
-
Duke UniversityKriya TherapeuticsRecruitingGlycogen Storage Disease VI | GLYCOGEN STORAGE DISEASE IXa1 | GLYCOGEN STORAGE DISEASE IXa2 | Glycogen Storage Disease IXB | Glycogen Storage Disease IXC | GSD 9 (All Subtypes) | GSD 6United States
-
University Medical Center GroningenUltragenyx Pharmaceutical IncCompletedGlycogen Storage Disease Type IANetherlands
-
John MitchellCompletedGlycogen Storage Disease Type III | Glycogen Storage Disease Type IA | Glycogen Storage Disease Type IB | Glycogen Storage Disease Type 0Canada
-
CENTOGENE GmbH RostockWithdrawnFructose Metabolism, Inborn Errors | Glycogen Storage Disease Type II | Glycogen Storage Disease | Glycogen Storage Disease Type V | Glycogen Storage Disease Type I | Glycogen Storage Disease Type III | Glycogen Storage Disease Type VII | Glycogen Storage Disease Type IV | Glycogen Storage Disease Type... and other conditionsGermany, India, Sri Lanka
-
Ultragenyx Pharmaceutical IncActive, not recruitingGlycogen Storage Disease Type IAUnited States, Brazil, Canada, Denmark, Germany, Italy, Netherlands, Spain
-
Ultragenyx Pharmaceutical IncCompletedGlycogen Storage Disease Type IANetherlands, United States
-
Ultragenyx Pharmaceutical IncActive, not recruitingGlycogen Storage Disease Type IA | Von Gierke's Disease (GSD Type Ia)Netherlands, United States, Canada, Spain
-
Sanguine BiosciencesTerminatedGlycogen Storage Disease Type IBUnited States
-
Spark TherapeuticsActive, not recruitingLysosomal Storage Diseases | Glycogen Storage Disease Type II | Glycogen Storage Disease Type 2 | Pompe Disease (Late-onset) | Pompe Disease | LOPD | Acid Maltase DeficiencyUnited States, Canada, Netherlands, France, Denmark, Germany, Italy, United Kingdom
-
Spark TherapeuticsCompletedLysosomal Storage Diseases | Glycogen Storage Disease Type 2 | Pompe Disease (Late-onset) | Pompe Disease | LOPD | Acid Maltase DeficiencyUnited States, Italy, United Kingdom, Netherlands, France, Germany